Clesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing ...

Shawn Johnson shares daughter Drew Hazel, 4, and sons Jett James, 2, and Barrett 'Bear' Madison, 10 months, with her husband ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

Respiratory syncytial virus (RSV) season has begun in our area, and we are already seeing babies being hospitalized. RSV is a ...

Doctors have issued a warning to parents over a common bug which can cause dangerous lung infections - with babies and young ...

RSV, or Respiratory Syncytial Virus, is a highly contagious virus that frequently spreads among preschool children, ...

WellSpan Ephrata Community Hospital is now offering respiratory syncytial virus immunizations to infants born at the hospital ...

An uptick in RSV infections has seen more babies admitted to hospital with severe chest infections, the UK Health Security ...

The effectiveness of the long-acting monoclonal antibody nirsevimab (Beyfortus) against primary care visits for lower ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

The drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.